Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapiesIsett Laux, David B. Agus(Cedars-Sinai Medical Center)British Journal of CancerNovember 22, 200510.1038/sj.bjc.6602875Cited by 69SaveCiteExport RISWatch citationsRelated PapersHER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation|Cancer Research|2010|67